Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells

BACKGROUND: Traditional Chinese medicine Tongxinluo (TXL) has been widely used to treat coronary artery disease in China, since it could reduce myocardial infarct size and ischemia/reperfusion injury in both non-diabetic and diabetic conditions. It has been shown that TXL could regulate peroxisome p...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Kang, Yang, Yuejin, Geng, Yongjian, Cui, Hehe, Li, Xiangdong, Jin, Chen, Chen, Guihao, Tian, Xiaqiu, Meng, Xianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447398/
https://www.ncbi.nlm.nih.gov/pubmed/32846824
http://dx.doi.org/10.1097/MD.0000000000021821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447398/
https://www.ncbi.nlm.nih.gov/pubmed/32846824
http://dx.doi.org/10.1097/MD.0000000000021821

Ejemplares similares